Detalhe da pesquisa
1.
Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies.
Blood;
2024 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38620092
2.
Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL.
Blood;
141(5): 519-528, 2023 02 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36084320
3.
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
N Engl J Med;
380(23): 2225-2236, 2019 Jun 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31166681
4.
Frailty is also a target for targeted drugs in CLL.
Blood;
142(13): 1107-1108, 2023 09 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37768694
5.
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL.
Blood;
131(9): 955-962, 2018 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29255066
6.
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).
Haematologica;
105(11): 2598-2607, 2020 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33131249
7.
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription.
Haematologica;
105(5): 1379-1390, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31467127
8.
[Multiple myeloma in old people : Practical skills for geriatricians and general practitioners]. / Multiples Myelom bei Älteren : Praxiswissen für Geriater und Allgemeinmediziner.
Z Gerontol Geriatr;
53(3): 263-272, 2020 May.
Artigo
em Alemão
| MEDLINE
| ID: mdl-32130502
9.
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
Am J Hematol;
94(9): 1002-1006, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31222797
10.
Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.
Br J Haematol;
183(5): 727-735, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30460980
11.
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.
Blood;
128(3): 395-404, 2016 07 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27226433
12.
Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.
Blood;
127(2): 208-15, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26486789
13.
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.
N Engl J Med;
370(12): 1101-10, 2014 Mar 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24401022
14.
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.
Br J Cancer;
114(8): 855-62, 2016 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27031850
15.
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab.
Blood;
133(5): 494-497, 2019 01 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30455380
16.
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age.
Haematologica;
105(5): 1183-1188, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32241848
17.
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG).
Haematologica;
100(11): 1451-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26315931
18.
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
Blood;
129(19): 2702-2705, 2017 05 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28325865
19.
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.
Haematologica;
99(6): 1095-100, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24584349
20.
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.
Blood;
117(6): 1817-21, 2011 Feb 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21139079